Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics entering the...
Descrease article font size Increase article font size Health Canada is warning Canadians of the dangers of buying “fake or unauthorized products” meant to replicate...